We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Akers Bio | LSE:AKR | London | Ordinary Share | COM SHS NPV |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 57.50 | 50.00 | 65.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
13/8/2017 11:11 | love it, that's in the header (ie there for all to see) - and the rise is from an all time low? | mcmather | |
13/8/2017 10:06 | Quite a move on the Nasdaq yesterday for AKR (see chart in header) 13% up | love it | |
08/8/2017 07:54 | out with the old and in with new blood to run the company which is a positive. | love it | |
07/8/2017 14:46 | Or next Monday when results are issued on the Nasdaq the price here will recover. If sales continue to increase as they are they will quickly move from losses to profits. | love it | |
04/8/2017 10:39 | A hemorrhaging patient unlikely to bounce | norbus | |
04/8/2017 09:53 | Strange it rose all day on the Nasdaq yesterday and here it's down but I still think it will bounce one the spread narrows. Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), ("Akers Bio" or the "Company"), a developer of rapid health information technologies, announces that sales in the second quarter ended June 30, 2017 were among the strongest since the Company's admission to NASDAQ Capital Market in 2014. The Company recorded revenues of approximately $1.2 million over the three-month period, representing an increase of approximately 25 per cent over the second quarter of 2016, and a 1.8 times increase over the first quarter of 2017. Revenues were derived from product sales in all key geographic regions (U.S., China and Rest of World) and were comprised of sales across Akers Bio's core commercialized product lines including components associated with the Company's PIFA Heparin/PF4 Rapid Assay products for sale internationally, and MPC breathalyzer based products. | love it | |
04/8/2017 08:31 | Dead corpse walking | norbus | |
04/8/2017 08:11 | Has the market missed the update late yesterday. I bought 1500 at open but the spread even online is shocking at 70-90p | love it | |
02/8/2017 08:28 | They may have sold some shares out of treasury | norbus | |
01/8/2017 22:53 | Nasdaq $1 - gormless gormally? I'll try to review the figures but whilst the previous monthly cash burn was said to be 'exceptional' (ie higher than it should have been for some questionable reason) if it had continued at that rate they would have run out of money by now. | mcmather | |
28/7/2017 08:48 | Why will wally weep? His milk cow about to go dry .. US$ MILLIONS went into this company and adding the measly sales it made was in excess of US$100m . Incompetent manager who would not allow any manager to try and make something for shareholders outside the benefit society. Thomas Nicorette had a plan, which imo would have taken AKR to safe shores but wally saw this might kill his milk cow hence Tom was off. Sad | norbus | |
26/7/2017 11:12 | This would be better described as a charitable contribution. | norbus | |
26/7/2017 09:22 | ah ok.Has the benefit of the doubt we were giving him finally ended then.It looks that way. Back to Watership Down and the death of Rabbits then. Must admit not one of my better investments this share. | algernon2 | |
26/7/2017 07:58 | Wally has set AKR up as a benefit society for Wally ripping the punters, just missing the huge breakthrough every now and then. Time has run out for this basket case. Musical chairs with management will not help. DYOR always, | norbus | |
25/7/2017 18:31 | Sorry are we talking metaphors or what? Please all be a little less obscure. | algernon2 | |
25/7/2017 17:13 | Walt is out of jail. | mcmather | |
25/7/2017 15:33 | Whats up doc? as Bugs Bunny might ask. | algernon2 | |
14/7/2017 13:35 | Bill is there to show them the ropes They will need to buy more boardroom chairs ; | norbus | |
14/7/2017 09:49 | Bill J White might be busy. "Mr White is a Certified Fraud Examiner". | mcmather |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions